A detailed history of Carolinas Wealth Consulting LLC transactions in Haemonetics Corp stock. As of the latest transaction made, Carolinas Wealth Consulting LLC holds 28 shares of HAE stock, worth $2,325. This represents 0.0% of its overall portfolio holdings.

Number of Shares
28
Previous 10 180.0%
Holding current value
$2,325
Previous $0 Infinity%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$71.24 - $85.35 $1,282 - $1,536
18 Added 180.0%
28 $2,000
Q3 2023

Nov 14, 2023

SELL
$82.56 - $93.49 $165 - $186
-2 Reduced 16.67%
10 $0
Q1 2023

May 15, 2023

BUY
$72.75 - $90.6 $873 - $1,087
12 New
12 $0

Others Institutions Holding HAE

About HAEMONETICS CORP


  • Ticker HAE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 51,316,500
  • Market Cap $4.26B
  • Description
  • Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...
More about HAE
Track This Portfolio

Track Carolinas Wealth Consulting LLC Portfolio

Follow Carolinas Wealth Consulting LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Carolinas Wealth Consulting LLC, based on Form 13F filings with the SEC.

News

Stay updated on Carolinas Wealth Consulting LLC with notifications on news.